Bilan semestriel du contrat de liquidité avec Invest Securities

OSE Immunotherapeutics reported the cash and securities amounts held in its liquidity account as of 30 June 2026 under its contract with Invest Securities. The excerpt provides procedural holdings data without commentary on financial performance or outlook.

Analysis

OSE Immunotherapeutics reported the cash and securities amounts held in its liquidity account as of 30 June 2026 under its contract with Invest Securities. The excerpt provides procedural holdings data without commentary on financial performance or outlook.